Welcome to Our Site
Our site provides investors with company-
specific data on publicy traded Israeli
stocks in Tel Aviv, Israeli companies
traded globally as well as up-to-date
information on Israel and its economy.
Globes, 6/3/2014 - Teva VP Ika Abravanel resignsRead More >>
Abravanel's is the first senior departure from Teva since Erez Vigodman became CEO.
Globes, 6/3/2014 - Cellcom 2013 profit down 46%Read More >>
CEO Nir Sztern: Price erosion in the cellular market will continue in the coming year.
Globes, 5/3/2014 - Desheh: Splitting Teva will not create valueRead More >>
According to Teva CFO Eyal Desheh, Teva's tight integration means that a split makes no sense.
Haaretz.com, 4/3/2014 - Teva launches first inhalable antipsychotic drug in U.S.Read More >>
Evogene - Evogene - The Street
Evogene IPO Sprouts Higher
Aspen Groups's Wholly-Owned Subsidiary Aspen Solar Purchases Brimag Energy Investments >>
Elbit Systems of America Awarded Contract for the U.S. Customs Border Protection Integrated Fixed Towers Project >>
RedHill Biopharma to Present at the 26th Annual ROTH Conference >>
RedHill Biopharma Provides Update on RHB-102 Development and Intellectual Property >>
BioLineRx Closes $24.1 Million Underwritten Public Offering of its American Depositary Shares >>
Teva Announces Launch of Generic Xeloda® Tablets 150 MG and 500 MG in the United States >>
Evogene Enhances Predictive Gene Stacking Capabilities >>
Tel Aviv Stock Exchange Weekly Review 2-6 March 2014 >>
Reprinted from the Equities Israel web site - www.equities.co.il